ARCHIVES

FDA Proposes New User Fees for Generics and Biosimilar Products

This article is from The Cancer Letter archive.

Vol. 38 No. 03 | January 20, 2012

Download PDF Visit The Full Archive

Related Articles

Cancer Genetics Network approved By NCI Advisors, To Start With 8 Centers

November 29, 1996

NCI Goofs On Contract Notice, Won’t Change Improper Deadline

April 15, 1977

Cancer Research Faces A “Strategic Inflection,” NCI Director Says

April 19, 2002

DCPC Board Defers Decision On Hepatitis Vaccine Study, Rejects PAP Sensitivity Concepts

June 1, 1984

Abstracts Of Papers From Gynecologic Oncology Conference

October 17, 1975

DCPC Board Asks More Money For Cancer Control In Centers, Urges Support Of Measure On Employment Discrimination

October 3, 1986